Literature DB >> 20049533

Study of inborn errors of metabolism in urine from patients with unexplained mental retardation.

Angela Sempere1, Angela Arias, Guillermo Farré, Judith García-Villoria, Pilar Rodríguez-Pombo, Lurdes R Desviat, Begoña Merinero, Angels García-Cazorla, Maria A Vilaseca, Antonia Ribes, Rafael Artuch, Jaume Campistol.   

Abstract

Mental retardation (MR) is a common disorder frequently of unknown origin. Because there are few studies regarding MR and inborn errors of metabolism (IEM), we aimed to identify patients with IEM from a cohort of 944 patients with unexplained MR. Biochemical examinations such as determination of creatine (Cr) metabolites, acylcarnitines, purine, and pyrimidines in urine were applied. We found seven patients with IEM [three with cerebral Cr deficiency syndromes (CCDS)], one with adenylosuccinate lyase (ADSL) deficiency, and three, born before the neonatal metabolic screening program in Catalonia, with phenylketonuria (PKU). All told, they represent 0.8% of the whole cohort. All of them had additional symptoms such as epilepsy, movement disorders, autism, and other psychiatric disturbances. In conclusion, in patients with MR, it is essential to perform a thorough appraisal of the associated signs and symptoms, and in most disorders, it is necessary to apply specific analyses. In some cases, it is important to achieve an early diagnosis and therapy, which may reduce the morbimortality, and to offer genetic counselling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20049533     DOI: 10.1007/s10545-009-9004-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  31 in total

1.  Medical evaluation of persons with mental retardation referred for psychiatric assessment.

Authors:  R Ryan; K Sunada
Journal:  Gen Hosp Psychiatry       Date:  1997-07       Impact factor: 3.238

2.  High frequency of creatine deficiency syndromes in patients with unexplained mental retardation.

Authors:  L Lion-François; D Cheillan; G Pitelet; C Acquaviva-Bourdain; G Bussy; F Cotton; L Guibaud; D Gérard; C Rivier; C Vianey-Saban; C Jakobs; G S Salomons; V des Portes
Journal:  Neurology       Date:  2006-11-14       Impact factor: 9.910

3.  Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening.

Authors:  Angela Arias; Marc Corbella; Carmen Fons; Angela Sempere; Judit García-Villoria; Aida Ormazabal; Pilar Poo; Mercé Pineda; María Antonia Vilaseca; Jaume Campistol; Paz Briones; Teresa Pàmpols; Gajja S Salomons; Antonia Ribes; Rafael Artuch
Journal:  Clin Biochem       Date:  2007-08-10       Impact factor: 3.281

Review 4.  Adenylosuccinate lyase deficiency.

Authors:  Erin K Spiegel; Roberta F Colman; David Patterson
Journal:  Mol Genet Metab       Date:  2006-07-12       Impact factor: 4.797

5.  Metabolic studies in older mentally retarded patients: significance of metabolic testing and correlation with the clinical phenotype.

Authors:  G J Van Buggenhout; J M Trijbels; R Wevers; J C Trommelen; B C Hamel; H G Brunner; J P Fryns
Journal:  Genet Couns       Date:  2001

6.  Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging.

Authors:  Amy Newmeyer; Kim M Cecil; Mark Schapiro; Joseph F Clark; Ton J Degrauw
Journal:  J Dev Behav Pediatr       Date:  2005-08       Impact factor: 2.225

7.  A longitudinal study of antioxidant status in phenylketonuric patients.

Authors:  Rafael Artuch; Catrina Colomé; Cristina Sierra; Nuria Brandi; Nilo Lambruschini; Jaume Campistol; Dolores Ugarte; Maria A Vilaseca
Journal:  Clin Biochem       Date:  2004-03       Impact factor: 3.281

8.  Stability of urinary glycosaminoglycans in patients with mucopolysaccharidoses.

Authors:  Fernando Andrade; José Angel Prieto; Javier Elorz; Sergio Martín; Pablo Sanjurjo; Luis Aldámiz-Echevarría
Journal:  Clin Chim Acta       Date:  2007-10-11       Impact factor: 3.786

9.  Gas-chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias.

Authors:  K Tanaka; A West-Dull; D G Hine; T B Lynn; T Lowe
Journal:  Clin Chem       Date:  1980-12       Impact factor: 8.327

10.  D-ribose therapy in four Polish patients with adenylosuccinate lyase deficiency: absence of positive effect.

Authors:  A Jurecka; A Tylki-Szymanska; M Zikanova; J Krijt; S Kmoch
Journal:  J Inherit Metab Dis       Date:  2008-07-12       Impact factor: 4.982

View more
  9 in total

1.  Molecular characterization of the AdeI mutant of Chinese hamster ovary cells: a cellular model of adenylosuccinate lyase deficiency.

Authors:  Lydia K Vliet; Terry G Wilkinson; Nathan Duval; Guido Vacano; Christine Graham; Marie Zikánová; Vaclava Skopova; Veronika Baresova; Aleš Hnízda; Stanislav Kmoch; David Patterson
Journal:  Mol Genet Metab       Date:  2010-09-06       Impact factor: 4.797

2.  Genetic and metabolomic analysis of AdeD and AdeI mutants of de novo purine biosynthesis: cellular models of de novo purine biosynthesis deficiency disorders.

Authors:  Nathan Duval; Kyleen Luhrs; Terry G Wilkinson; Veronika Baresova; Vaclava Skopova; Stanislav Kmoch; Guido N Vacano; Marie Zikanova; David Patterson
Journal:  Mol Genet Metab       Date:  2013-01-12       Impact factor: 4.797

Review 3.  Metabolic evaluation of children with global developmental delay.

Authors:  So-Hee Eun; Si Houn Hahn
Journal:  Korean J Pediatr       Date:  2015-04-22

4.  Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD).

Authors:  Martha Spilioti; Athanasios E Evangeliou; Despoina Tramma; Zoe Theodoridou; Spyridon Metaxas; Eleni Michailidi; Eleni Bonti; Helen Frysira; A Haidopoulou; Despoina Asprangathou; Aggelos J Tsalkidis; Panagiotis Kardaras; Ron A Wevers; Cornelis Jakobs; K Michael Gibson
Journal:  Front Hum Neurosci       Date:  2013-12-24       Impact factor: 3.169

Review 5.  Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies.

Authors:  Michele Malaguarnera; Omar Cauli
Journal:  Molecules       Date:  2019-11-22       Impact factor: 4.411

6.  Paediatric genomic testing: Navigating medicare rebatable genomic testing.

Authors:  Rani Sachdev; Mike Field; Gareth S Baynam; John Beilby; Maria Berarducci; Yemima Berman; Tiffany Boughtwood; Marie B Cusack; Vanessa Fitzgerald; Jeffery Fletcher; Mary-Louise Freckmann; Natalie Grainger; Edwin Kirk; Ben Lundie; Sebastian Lunke; Lesley McGregor; David Mowat; Gayathri Parasivam; Vanessa Tyrell; Mathew Wallis; Susan M White; Alan S L Ma
Journal:  J Paediatr Child Health       Date:  2021-02-10       Impact factor: 1.954

7.  Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.

Authors:  Tobias S Hagedorn; Paul van Berkel; Gregor Hammerschmidt; Markéta Lhotáková; Rosalia Pasqual Saludes
Journal:  Orphanet J Rare Dis       Date:  2013-12-17       Impact factor: 4.123

Review 8.  Diagnosis of Mucopolysaccharidoses.

Authors:  Francyne Kubaski; Fabiano de Oliveira Poswar; Kristiane Michelin-Tirelli; Maira Graeff Burin; Diana Rojas-Málaga; Ana Carolina Brusius-Facchin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Diagnostics (Basel)       Date:  2020-03-22

9.  Inducible Slc7a7 Knockout Mouse Model Recapitulates Lysinuric Protein Intolerance Disease.

Authors:  Susanna Bodoy; Fernando Sotillo; Meritxell Espino-Guarch; Maria Pia Sperandeo; Aida Ormazabal; Antonio Zorzano; Gianfranco Sebastio; Rafael Artuch; Manuel Palacín
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.